🔧 PerMedCoE has prioritised two of the five use cases designed to test its core applications: the study of drug synergies and the study of COVID-19.

Intranet
🔧 PerMedCoE has prioritised two of the five use cases designed to test its core applications: the study of drug synergies and the study of COVID-19.
📽 Recording of PerMedCoE’s session at the PATC-CompBioMed short course on HPC-based Computational Bio-Medicine is now available!
🔧 PerMedCoE’s work on optimisation and usability aims to optimise the implementation of personalised medicine software on HPC environments.
📰 PerMedCoE’s work on COVID-19 modelling is showcased by Focus CoE in their summary of HPC CoEs’ use cases.
📰 PerMedCoE will work on five use cases to drive the development of cell-level simulations to have examples of specific implementations of personalised medicine solutions in HPC/Exascale environments.